Incontinence News and Research

Latest Incontinence News and Research

Prostate cancer treatment leads to declines in sexual and urinary function

Treatment for prostate cancer leads to significant five-year declines in sexual and urinary function, according to a new study. However, general and other specific health-related quality of life factors, such as bowel function, are not affected.

27 Sep 2004

A low salt diet can be extremely dangerous for elderly people

Professor Füsgen presented his findings at the European Geriatrics Congress in Vienna, which ended yesterday (September 19). They show that the symptoms of hyponatraemia (low sodium level in the blood), which are tiredness, difficulty in concentrating and loss of balance, can develop into confusion and even coma if left untreated.

20 Sep 2004

European positive for Cymbalta and Xeristar

Eli Lilly and Company and Boehringer Ingelheim have announced that the Committee for Medicinal Products in Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of duloxetine for the treatment of major depressive episodes.

20 Sep 2004

Yentreve available in Europe for treatment of stress urinary incontinence

Yentreve (duloxetine hydrochloride) is now available in certain European countries, giving women suffering from moderate to severe stress urinary incontinence (SUI) a pharmaceutical treatment option for the first time.

13 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004

Are Latin America and the Caribbean ready to meet the health challenges of the coming senior boom?

Advances in medicine and public health have dramatically increased life expectancy in Latin America and the Caribbean.But is the region ready to meet the challenges of the coming "senior boom"?

31 Aug 2004

Cymbalta, treatment for major depression hits the market

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company has announced.

26 Aug 2004

Cymbalta, a new treatment for major depression

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company have announced.

25 Aug 2004

Pfizer drug effectively treats overactive bladder symptoms

Women with mixed incontinence, a combination of overactive bladder and stress incontinence, reported a greater treatment benefit for overactive bladder symptoms from DETROL® LA (tolterodine tartrate extended release capsules) than placebo, according to new study results published in the August issue of Urology.

21 Aug 2004

Evidence of pelvic floor nerve injury after routine vaginal birth

Women with pelvic floor disorders suffer from urinary and fecal incontinence as well as prolapse of the bowel, bladder and reproductive organs. (Bowel prolapse occurs when the bowel slips out of place, and pushes up against the walls of the vagina, which may cause a great deal of discomfort.)

20 Aug 2004

Study to compare prostate surgery and drugs

The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride.

20 Aug 2004

Researchers find way to detect dangerous brain swelling in diabetic children

A rare swelling of the brain that is nonetheless the most common diabetes-related cause of death for children with the disease could be caught earlier — potentially saving lives — if practitioners learn to recognize key signs, researchers at the University of Florida report.

18 Aug 2004

Approval of Cymbalta for treatment of major depressive disorder

The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.

5 Aug 2004

State-of-the-art laparoscopic robotic technology sends most prostate patients home the day after surgery

As recently as three years ago, the gold standard to treat prostate cancer, the second most common form of cancer in men, was an invasive surgery that required up to a one-week hospital stay.

2 Aug 2004

New tool that measures and assesses first and second-degree perineal tears

A researcher from the University of Birmingham has co-developed a device to significantly improve the maternity aftercare of many new mothers - and the invention could also help lead the way in forensic investigations.

9 Jul 2004

TUNA therapy results in significantly reduced erectile dysfunction

Comparing five-year results of Medtronic TUNA® Therapy (transurethral needle ablation) to surgery for 121 men in their mid-60s with lower urinary tract symptoms caused by an enlarged prostate, a team of urologists found that “for appropriately selected patients with bothersome voiding symptoms, TUNA is an attractive treatment option.”

1 Jul 2004